Fueled by a unique company culture, we are researching & developing life-changing gene therapies for people with devastating inherited neurological conditions.
SwanBio is now part of Spur Therapeutics! Our potential first-in-class gene therapy candidate for #adrenomyeloneuropathy (#AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at https://t.co/qEdprnQEfD and follow our progress @spurtherapeutx
#BIO2023 has officially begun! We are so excited to stand up for science, celebrate, and recognize the true value of the work biotech performs for society.
We often hear how helpful these virtual support groups can be to families impacted by #rarediseases like #adrenomyeloneuropathy. Please check this out or pass along.
Join us tomorow, May 31st! We will discuss ways to cope with everyday stressors that caregivers regularly face within the leukodystrophy community.
The sessions are confidential and will not be recorded
Register at https://t.co/MXbi4cIIFe
#ulf#leukodystrophy#notgivingup
Meet the Life Sciences & Healthcare CEO 🏅 Finalists:
Tom Anderson, SwanBio Therapeutics 🦢
Hervé Hoppenot, Incyte 🧬
Melissa Sherman, MOBILion Systems 🧪
Big thanks to sponsors @EYnews and @MorganLewisLaw
RSVP for the #Enterprise Awards on 5/23 👉 https://t.co/leZ17FIzDv
You may know us as a product company, but you may not have heard about the vector engineering platform that is powering our future pipeline. Read more from #ASGCT23: https://t.co/C29cvpbok9 #genetherapy#raredisease
🎉 Get ready for the PARTY of the YEAR! Join us at the Enterprise Awards on 5/23 as we celebrate the BEST in tech, life sciences, innovation & investment!
Don't miss an electrifying night of networking, delicious food, and endless inspiration!
RSVP @ https://t.co/14yszED9B9
Deep understanding of rare neurological disease is essential for R&D of meaningful therapies. That's why we're investing in studies about the experiences of patients with adrenomyeloneuropathy (#AMN). Sharing more at #AANAM: https://t.co/8RorM4n10L
Join us tomorrow! We will discuss ways to cope with everyday stressors that caregivers regularly face within the leukodystrophy community.
The sessions are confidential and will not be recorded
Register at https://t.co/B1ynTIlarP
#ulf#leukodystrophy#notgivingup
Cheers to 75 years! 🥂
The AAN was founded on this day in 1948. Since then, we've transformed to respond to the needs of neurologists and #neurology professionals to help them provide the best #PatientCare.
Learn more about our history: https://t.co/kebYPqLz9z
#NeurologyProud
🎉 Philadelphia has cracked the top five nationally in closed deals for 2022. Want to learn more about Philadelphia's growth in 2022? Check out the Philadelphia Venture Report at https://t.co/1YofhlbzES.
#PhiladelphiaVentureReport#Entrepreneurship#EquitableGrowth
One mission of #InternationalWomensDay is to forge #inclusive work cultures where women’s careers thrive.
We are incredibly proud of intentional decisions we make to foster female leadership - and the fact that > 60% of our org is female.
Ahead of #RareDiseaseDay on February 28th, we are providing open access with registration to some of our analysis about drug development for rare diseases. Read and share our content, and learn more about rare diseases > https://t.co/AAh4jQhx47
This #blackhistorymonth we’re proud that part of our DE&I efforts is a focus on fostering an interest in STEM among young people in our communities. Learn more: https://t.co/bFpCheuNAP
📣 PACT announced the list of finalists for this year's Enterprise Awards - the region's most prestigious honors for leaders in life sciences & technology.
Snag your tickets 5/23's in-person ceremony (& see the full list of nominees) at https://t.co/LjvaVJByKF
Today is our fifth birthday! It couldn't be more fitting that the month of our founding is the same month as #RareDiseaseDay. After all, every day we are driven by a sense of urgency for people living with rare diseases.